TMDX TransMedics Group, Inc.
$66.90▼ -4.06%
Healthcare
Other
After hours
$67.02▲ +0.18%
Oct 28, 6:39 PM ET
Volume 1.18M
Avg Volume (10D) 869.8K
Key Metrics & Fundamentals
Market Cap
$2.32B
P/E Ratio
17.3
Div Yield
0.00%
52W Range
60.11 - 156.00
% vs 50 MA
-19.09%
% vs 200 MA
-29.76%
RSI-14
29.8
MACD Histogram
-0.6000
Beta (1Y vs SPY)
1.08
Free Cash Flow
$10.22M
Gross Rev
$189.95M
Gross Profit
$113.20M
EBITDA
$36.97M
COGS
$76.75M
Operating Exp
$89.46M
Operating Income
$23.74M
EBIT
$23.74M
Pretax Income
$19.41M
Net Income
$14.68M
EPS (Diluted)
0.41
Price & Volume History
Loading chart…
Recent News

TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026
PR Newswire · Oct 22, 2026 4:05 PM ET

TransMedics Group (TMDX) Stock Looks Undervalued On Current Earnings
Simply Wall St. · Oct 17, 2026 2:12 PM ET

Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET

TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings
Simply Wall St. · Oct 2, 2026 5:07 AM ET

TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds
Simply Wall St. · Oct 2, 2026 2:07 AM ET

TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
Motley Fool · Sep 29, 2026 12:37 PM ET

2 Stocks Down 28% and 34% to Buy and Hold
Motley Fool · Sep 15, 2026 10:20 AM ET
TransMedics Names Fernando Araujo as CFO; Maintains 2026 Revenue Outlook
MT Newswires · Sep 10, 2026 4:45 PM ET

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
PR Newswire · Sep 10, 2026 4:05 PM ET

Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
Zacks · Sep 3, 2026 2:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TMDX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.